A Study of mRNA-1010 Compared With a Licensed Influenza Vaccine in Adults ≥50 Years of Age

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2024
The primary objectives of this study are to evaluate the safety and reactogenicity of mRNA-1010, and to evaluate relative vaccine efficacy (rVE) of mRNA-1010 versus an active comparator against protocol-defined influenza-like illness (ILI) caused by any influenza A or B strains.
Epistemonikos ID: 7e728a9d540a42d8afaa0903c0376ae602e621ef
First added on: Oct 01, 2024